research roi tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide 5mg GIP/GLP-1 Receptor Agonist

The references below are starting points for the mechanisms discussed here

Patients should maintain consistent fluid intake throughout the day, guided by thirst, urine color (pale yellow indicates adequate hydration), and individual needs

The request is not for the continuation of therapy, and

Branded Mounjaro lists common side effects that include: Nausea Diarrhea Reduced appetite Vomiting Constipation Indigestion Abdominal pain The frequency, severity, and cause of side effects with compounded products may vary because the formulation and dose can differ from those of the FDA-approved product

Food and Drug Administration (FDA) for safety or efficacy